Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2684 |
|
| Actual shortage: | 240 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2435 (91%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-METFORMIN | 850MG | TABLET | Resolved | 2020-04-02 | 2020-05-14 | 110649 |
| ACT LEVOFLOXACIN | 750MG | TABLET | Resolved | 2020-04-02 | 2020-05-14 | 110655 |
| TEVA-MODAFINIL | 100MG | TABLET | Resolved | 2020-04-02 | 2020-05-14 | 110709 |
| TEVA-TELMISARTAN HCTZ | 80.0MG 25.0MG | TABLET | Resolved | 2020-04-03 | 2020-05-14 | 110788 |
| TEVA-PROPOFOL | 10MG | EMULSION | Actual shortage | 2020-04-10 | 2020-05-14 | 111871 |
| TEVA-LORAZEPAM | 1MG | TABLET | Resolved | 2020-05-01 | 2020-05-14 | 113770 |
| TEVA-LORAZEPAM | 0.5MG | TABLET | Resolved | 2020-05-08 | 2020-05-14 | 114430 |
| TEVA-LORAZEPAM | 1MG | TABLET | Resolved | 2020-05-08 | 2020-05-14 | 114433 |
| TEVA-PERINDOPRIL/INDAPAMIDE | 4MG 1.25MG | TABLET | Resolved | 2020-04-02 | 2020-05-14 | 110703 |
| TEVA-EVEROLIMUS | 2.5MG | TABLET | Resolved | 2020-04-10 | 2020-05-14 | 111807 |
| TEVA-PROPRANOLOL | 80MG | TABLET | Resolved | 2020-05-01 | 2020-05-14 | 113741 |
| TEVA-TELMISARTAN | 80MG | TABLET | Resolved | 2018-11-20 | 2020-05-14 | 67231 |
| TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2019-10-17 | 2020-05-21 | 96724 |
| TEVA-QUETIAPINE XR | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-03-06 | 2020-05-21 | 107986 |
| NOVO-GESIC | 325MG | TABLET | Resolved | 2020-03-26 | 2020-05-21 | 109571 |
| ACT CIPROFLOXACIN | 500MG | TABLET | Resolved | 2020-04-02 | 2020-05-21 | 110643 |
| TEVA-BISOPROLOL | 5MG | TABLET | Resolved | 2020-04-02 | 2020-05-21 | 110673 |
| TEVA-PREDNISONE | 5MG | TABLET | Resolved | 2020-04-03 | 2020-05-21 | 110770 |
| TEVA-PREDNISONE | 50MG | TABLET | Resolved | 2020-04-03 | 2020-05-21 | 110773 |
| TEVA-PROPRANOLOL | 40MG | TABLET | Resolved | 2020-04-10 | 2020-05-21 | 111835 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ATENOLOL | 50MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106142 |
| TEVA-ATENOLOL | 100MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106145 |
| RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2020-02-13 | 2020-02-13 | 106148 |
| RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106158 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106161 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106164 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
| LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 | ||
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 | ||
| TEVA-PAROXETINE | 10MG | TABLET | Discontinued | 2020-02-21 | 2020-02-21 | 106898 |
| TEVA-PAROXETINE | 30MG | TABLET | Discontinued | 2020-02-21 | 2020-02-21 | 106901 |
| ACT RANITIDINE | 150MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115079 |
| ACT RANITIDINE | 300MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115082 |
| TEVA-ARIPIPRAZOLE | 2MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115085 |
| CEFOXITIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2020-05-14 | 2020-05-14 | 115088 |
| TEVA-TRIAMTERENE/HCTZ | 50MG 25MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115091 |
| ACT DILTIAZEM T | 360MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115114 |